Clinical Trials · NCT00392925

A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects

Name: A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 2Pramlintide

Phase: Phase 2
Recruitment status: Completed
Sponsor: AstraZeneca
Enrollment: 177
Start date: Oct 2006
Locations: 12 sites, United States
Primary endpoint: Mean Absolute Change From Baseline to Week 16 in Body Weight - Evaluable Population

View Pramlintide compound reference